Skip to main content
Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

8 views
Download
Pharmaceutical

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Strength

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Pack Size

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Form

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Source

European Medicines Agency

View Source

Safety Profile

Contraindications

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Side Effects

Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Related Clinical Articles

Scan this QR code to access this page quickly on your mobile device.

QR Code